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Isolated erythematous plaque on the right cheekCase report
A 54-year-old man without underlying disease had one mild itchy
rash on the right cheek for 6 months. He tried topical ﬂuocinolone
acetonide ointment and the lesion became less itchy. However, the
rash enlarged gradually, so he came to our clinic. Cutaneous ﬁnding
was a 4  5 cm, erythematous-to-brownish plaque on the right
cheek with focal erosions. No lesions were found elsewhere
(Figure 1A). A skin biopsy was done, which revealed acantholytic
cells mainly in the granular layer and nonspeciﬁc perivascular andFigure 1 (A) One 4  5 cm, erythematous-to-brownish plaque on the right cheek with fo
200); (C) direct immunoﬂuorescence shows positive immunoglobulin G deposition at the
into one brownish patch after 5 months of treatment.
1027-8117/$ – see front matter Copyright  2012, Taiwanese Dermatological Associatio
http://dx.doi.org/10.1016/j.dsi.2012.08.001perifollicular inﬁltration in the dermis (Figure 1B). Focal hydropic
changes and pigment incontinencewere also present. Direct immu-
noﬂuorescence (DIF) showed positive immunoglobulin (Ig) G depo-
sition at the intercellular space and along the basement membrane
zone (BMZ; Figure 1C). Indirect immunoﬂuorescence (IIF) showed
anti-intercellular space antibody 1:80 (þ). Antinuclear antibody
(ANA)was 1:40() and antiextractable nuclear antigen (ENA) anti-
bodies were all negative. He was treated with oral prednisolone
50 mg daily by tapering dose during the following 5 months; the
lesion improved gradually (Figure 1D).cal erosions; (B) acantholytic cells mainly in the granular layer (hematoxylin & eosin,
intercellular space and along the basement membrane zone (100); (D) rash resolved
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Pemphigus erythematosus (PE).Discussion
PE is originally described as a variant of pemphigus with features of
lupus erythematosus (LE), such as typical butterﬂy pattern of facial
lesions, deposition of immunoglobulins at the dermoepidermal
junction, and LE features in the histopathology or serologic ﬁndings
of systemic LE.1,2 However, a true dual diagnosis of pemphigus and
systemic lupus erythematosus (SLE) is less common and the two
diseases appear to progress independently.2 The patients with
dual diagnosis are more similar to the demographic proﬁle of SLE
than pemphigus vulgaris, and nearly 100% of such patients are posi-
tive for ANA (ANA titer  1:80).3 Overall, a positive ANA is detected
in 30%–80% of patients with PE,3 and our patient had a negative
result of ANA.
Clinically, PE usually presents as small, ﬂaccid bullae with
scaling and crusting on the scalp, face, upper chest, and back. On
the face, PE presents on the bridge of the nose and on the malar
areas in a butterﬂy distribution as seen in LE.4 There is no report
of unilesional PE in the literature. However, unilesional lesions in
other immunologic diseases, such as LE, are occasionally reported.5
On histologic examination, pemphigus foliaceus and PE demon-
strate acantholysis just below the stratum corneum or within the
granular layer. The blister may contain numerous acute inﬂamma-
tory cells, particularly neutrophils. Lichenoid dermatitis might be
seen, but the lupus feature might not always exist.2,3
DIF and IIF could be a supportive evidence for diagnosis. DIF
shows IgG or C3 deposition on epidermal cell surfaces in 90%
patients and most, but not all patients (in 70%w80% patients
sampled from sun-exposed areas) have additional ﬁnding of gran-
ular IgG or C3 deposition at the BMZ.2,3IIF reveals 80%–100% posi-
tive of anti-intercellular space antibody (from 1:10 to 1:2560).2,3
Our case has the DIF result of IgG deposition both on epidermalcell surfaces and at the BMZ and the IIF result is anti-intercellular
space antibody 1:80 (þ).
Conclusion
PE is a superﬁcial form of pemphigus that shows some features of
LE. The course of PE is usually milder and it responds to lower doses
of systemic corticosteroids.3
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